The European Prospective Investigation into Cancer and Nutrition (EPIC) cohort study found that women with higher OPG serum levels had an increased relative risk (1.93) of developing estrogen receptor-negative (ER–) breast cancer [33]. The gene discussed is TNFRSF11B; the disease is breast cancer.